Back to KRYS
TRUIST FINANCIAL CORP KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
9
Latest value
$487K
Q3 2026
Peak value
$4.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $236K |
| Q4 2025 | $30K |
| Q1 2026 | $270K |
| Q1 2026 | $30K |
| Q2 2026 | $105K |
| Q2 2026 | $554K |
| Q3 2026 | $2K |
| Q3 2026 | $4.5M |
| Q3 2026 | $487K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $487K | 1.5K | — | — |
| Q3 2026 | $4.5M | 13.5K | — | — |
| Q3 2026 | $2K | 5 | — | — |
| Q2 2026 | $554K | 1.5K | — | — |
| Q2 2026 | $105K | 282 | — | — |
| Q1 2026 | $30K | 117 | — | — |
| Q1 2026 | $270K | 1.0K | — | — |
| Q4 2025 | $30K | 121 | — | — |
| Q4 2025 | $236K | 959 | — | — |
Other funds holding KRYS
$537.3M
$502.2M
$502.2M
$339.5M
$78.2M
$78.2M